JO
ANIX icon

John Overdeck’s Anixa Biosciences ANIX Stock Holding History

John Overdeck’s Portfolio ANIX Stock Details ANIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-14,492
Closed -$37.4K – 5045
2026
Q1 		$37.4K Buy
+14,492
New +$42.9K ﹤0.01% 4479
2022
Q1 		– Sell
-36,350
Closed -$108K – 2658
2021
Q4 		$108K Sell
36,350
-15,700
-30% -$63.5K ﹤0.01% 4048
2021
Q3 		$248K Sell
52,050
-400
-0.8% -$1.8K ﹤0.01% 3803
2021
Q2 		$204K Buy
+52,450
New +$223K ﹤0.01% 3776
2020
Q4 		– Sell
-39,491
Closed -$96K – 3306
2020
Q3 		$96K Buy
+39,491
New +$102K ﹤0.01% 2943

Other funds holding ANIX

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
LNWTC
Laird Norton Wetherby Trust Company Seattle, Washington $5.21B AUM 31.48% 1-Year Est. Return
DADC
D.A. Davidson & Co Great Falls, Montana $18.1B AUM 24.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

John Overdeck's ANIX Position: Q2 2026 in Review

John Overdeck sold out of Anixa Biosciences (ANIX) in Q2 2026, closing a stake of 14,492 shares — an estimated $37.4K sold.

John Overdeck first reported a position in ANIX in Q3 2020 and held it in 5 quarters. The position peaked at $248K in Q3 2021. 62 funds tracked by Wall St. Rank hold ANIX as of Q2 2026.

  • John Overdeck reported no remaining Anixa Biosciences position as of Q2 2026 after selling out during the quarter.
  • John Overdeck sold 14,492 Anixa Biosciences shares in Q2 2026, an estimated $37.4K.
  • John Overdeck first reported a position in Anixa Biosciences in Q3 2020 and held it in 5 quarters.
  • John Overdeck's Anixa Biosciences position peaked at $248K in Q3 2021.
  • 62 funds tracked by Wall St. Rank held Anixa Biosciences as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.